• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与加拿大 HPV 疫苗接种年轻女性对细菌性性传播感染疫苗接种意愿相关的因素。

Factors associated with intention to receive vaccines for bacterial sexually transmitted infections among young HPV-vaccinated Canadian women.

机构信息

Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

BC Women's Hospital and Health Service, Women's Health Research Institute, Box 42, Room H203G - 4500 Oak Street, Vancouver, BC, V6H 3N1, Canada.

出版信息

Can J Public Health. 2022 Oct;113(5):776-785. doi: 10.17269/s41997-022-00648-2. Epub 2022 May 26.

DOI:10.17269/s41997-022-00648-2
PMID:35616872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9134722/
Abstract

OBJECTIVE

The aim of this study was to explore the acceptability of bacterial STI vaccines among young HPV-vaccinated Canadian women to inform future vaccine program implementation.

METHODS

A 20-item cross-sectional questionnaire was administered from June 2019 to June 2020 to HPV-vaccinated participants of the pan-Canadian QUEST cohort. Multivariable logistic regression models assessed interest in chlamydia, syphilis, and gonorrhea vaccines using a priori variables and factors significant in bivariate analysis.

RESULTS

Of the 1092 respondents analyzed, 82% indicated interest in receiving one or more future STI vaccines. Respondents had a median age of 19.6 years (range 16.9-23.4), and 75% of respondents identified as white/European descent. In adjusted analyses, intent to engage in positive health behaviours was associated with vaccine interest for syphilis (OR = 5.76, 95% CI 4.03-8.27), chlamydia (OR = 5.27, 95% CI 3.66-7.63), and gonorrhea (OR = 5.96, 95% CI 4.15-8.60). Willingness to pay for an STI vaccine was also associated with vaccine interest for syphilis (OR = 2.02, 95% CI 1.29-3.19), chlamydia (OR = 2.41, 95% CI 1.50-3.90), and gonorrhea (OR = 2.29, 95% CI 1.44-3.63). Ever having sexual intercourse and identifying as LGBTQ were significantly associated with vaccine interest for all infections, while age and ever being immunosuppressed were not significant in any adjusted models.

CONCLUSION

Findings indicate over 80% of participants in a cohort of young HPV-vaccinated Canadian women are interested in receiving future bacterial STI vaccines. Further exploration of STI vaccine acceptability among diverse populations is required to inform future bacterial STI vaccine program implementation.

摘要

目的

本研究旨在探讨加拿大 HPV 疫苗接种年轻女性对细菌性性传播感染疫苗的可接受性,以为未来疫苗规划的实施提供信息。

方法

2019 年 6 月至 2020 年 6 月,对泛加 QUEST 队列的 HPV 疫苗接种参与者进行了一项 20 项的横断面问卷调查。采用事先确定的变量和双变量分析中具有统计学意义的因素,多变量逻辑回归模型评估了对衣原体、梅毒和淋病疫苗的兴趣。

结果

在分析的 1092 名受访者中,82%的人表示有兴趣接种一种或多种未来的性传播感染疫苗。受访者的中位年龄为 19.6 岁(范围 16.9-23.4 岁),75%的受访者为白种/欧洲裔。在调整后的分析中,愿意采取积极的健康行为与对梅毒(OR=5.76,95%CI 4.03-8.27)、衣原体(OR=5.27,95%CI 3.66-7.63)和淋病(OR=5.96,95%CI 4.15-8.60)疫苗的接种意愿相关。愿意为性传播感染疫苗付费也与对梅毒(OR=2.02,95%CI 1.29-3.19)、衣原体(OR=2.41,95%CI 1.50-3.90)和淋病(OR=2.29,95%CI 1.44-3.63)疫苗的接种意愿相关。曾有过性行为和认定为 LGBTQ 与所有感染的疫苗接种意愿显著相关,而年龄和曾有免疫抑制则在任何调整后的模型中均不显著。

结论

研究结果表明,在 HPV 疫苗接种的年轻加拿大女性队列中,超过 80%的参与者有兴趣接种未来的细菌性性传播感染疫苗。需要进一步探讨不同人群对性传播感染疫苗的可接受性,以为未来细菌性性传播感染疫苗规划的实施提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b5b/9481762/639734214c49/41997_2022_648_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b5b/9481762/1ee5c7b534ac/41997_2022_648_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b5b/9481762/639734214c49/41997_2022_648_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b5b/9481762/1ee5c7b534ac/41997_2022_648_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b5b/9481762/639734214c49/41997_2022_648_Fig2_HTML.jpg

相似文献

1
Factors associated with intention to receive vaccines for bacterial sexually transmitted infections among young HPV-vaccinated Canadian women.与加拿大 HPV 疫苗接种年轻女性对细菌性性传播感染疫苗接种意愿相关的因素。
Can J Public Health. 2022 Oct;113(5):776-785. doi: 10.17269/s41997-022-00648-2. Epub 2022 May 26.
2
Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.HIV 阴性的西开普省年轻南非女性中 HPV 和性传播感染的流行模式及合并感染的相关因素:EVRI 试验。
Sex Transm Infect. 2018 Feb;94(1):55-61. doi: 10.1136/sextrans-2016-053046. Epub 2017 May 10.
3
Public willingness to receive chlamydia, gonorrhea, syphilis, and trichomoniasis vaccines: a scoping review.公众对接受衣原体、淋病、梅毒和滴虫病疫苗的意愿:范围综述。
BMC Health Serv Res. 2023 Nov 23;23(1):1290. doi: 10.1186/s12913-023-10334-9.
4
Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study.乌干达二价人乳头瘤病毒疫苗接种和未接种疫苗的年轻女性的宫颈癌风险认知、性风险行为和性传播感染——5年随访研究
BMC Womens Health. 2017 Jun 2;17(1):40. doi: 10.1186/s12905-017-0394-y.
5
Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis.美国有过性行为史的 18-35 岁女性中,人乳头瘤病毒疫苗接种状况与性传播感染结局的相关性:基于人群调查的横断面分析。
Vaccine. 2020 Dec 14;38(52):8396-8404. doi: 10.1016/j.vaccine.2020.10.033. Epub 2020 Nov 22.
6
Factors associated with interest in bacterial sexually transmitted infection vaccines at two large sexually transmitted infection clinics in British Columbia, Canada.加拿大不列颠哥伦比亚省两家大型性传播感染诊所中与细菌性传播感染疫苗接种意愿相关的因素。
Sex Transm Infect. 2020 Nov;96(7):494-500. doi: 10.1136/sextrans-2019-054311. Epub 2020 May 26.
7
Human papillomavirus vaccine-related risk perceptions and subsequent sexual behaviors and sexually transmitted infections among vaccinated adolescent women.接种疫苗的青春期女性中与人乳头瘤病毒疫苗相关的风险认知及随后的性行为和性传播感染
Vaccine. 2016 Jul 25;34(34):4040-5. doi: 10.1016/j.vaccine.2016.06.026. Epub 2016 Jun 10.
8
Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females.青春期女性接种人乳头瘤病毒疫苗后性传播感染的发生率
JAMA Intern Med. 2015 Apr;175(4):617-23. doi: 10.1001/jamainternmed.2014.7886.
9
[Sexually transmitted infections in Germany : The current epidemiological situation].[德国的性传播感染:当前的流行病学状况]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Sep;60(9):948-957. doi: 10.1007/s00103-017-2590-1.
10
Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.在乌干达一项二价HPV-16/18疫苗(希瑞适®)试点项目开展5.5年后,与未接种疫苗的年轻女性相比,接种疫苗的年轻女性中疫苗型HPV-16/18感染的基因流行率显著降低。
PLoS One. 2016 Aug 2;11(8):e0160099. doi: 10.1371/journal.pone.0160099. eCollection 2016.

引用本文的文献

1
Could APTIMA mRNA Assay Contribute to Predicting Cervical Bacterial Sexually Transmitted Co-Infections? A Colposcopy Population Study.APTIMA mRNA检测能否有助于预测宫颈细菌性性传播合并感染?一项阴道镜检查人群研究。
Int J Mol Sci. 2024 Dec 6;25(23):13146. doi: 10.3390/ijms252313146.
2
Cervical HPV Infections, Sexually Transmitted Bacterial Pathogens and Cytology Findings-A Molecular Epidemiology Study.宫颈人乳头瘤病毒感染、性传播细菌病原体与细胞学检查结果——一项分子流行病学研究
Pathogens. 2023 Nov 14;12(11):1347. doi: 10.3390/pathogens12111347.
3
Public willingness to receive chlamydia, gonorrhea, syphilis, and trichomoniasis vaccines: a scoping review.

本文引用的文献

1
Priorities for sexually transmitted infection vaccine research and development: Results from a survey of global leaders and representatives.性传播感染疫苗研发的优先事项:全球领导者和代表的调查结果
Vaccine X. 2021 Jun 29;8:100107. doi: 10.1016/j.jvacx.2021.100107. eCollection 2021 Aug.
2
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries.新冠病毒疫苗在中低收入国家的接受程度和犹豫。
Nat Med. 2021 Aug;27(8):1385-1394. doi: 10.1038/s41591-021-01454-y. Epub 2021 Jul 16.
3
The Development of Human Papillomavirus (HPV) Vaccines and Current Barriers to Implementation.
公众对接受衣原体、淋病、梅毒和滴虫病疫苗的意愿:范围综述。
BMC Health Serv Res. 2023 Nov 23;23(1):1290. doi: 10.1186/s12913-023-10334-9.
4
Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.韩国首尔地区母亲对为男童接种人乳头瘤病毒(HPV)疫苗的看法:一项描述性探索性定性研究。
PLoS One. 2023 Mar 10;18(3):e0282811. doi: 10.1371/journal.pone.0282811. eCollection 2023.
人乳头瘤病毒(HPV)疫苗的发展现状和实施的现存障碍。
Immunol Invest. 2021 Oct;50(7):821-832. doi: 10.1080/08820139.2021.1897612. Epub 2021 Mar 16.
4
COVID-19 Vaccine Hesitancy: Shortening the Last Mile.COVID-19 疫苗犹豫:缩短最后一英里。
Trends Cogn Sci. 2021 May;25(5):331-333. doi: 10.1016/j.tics.2021.02.002. Epub 2021 Feb 9.
5
Factors associated with interest in bacterial sexually transmitted infection vaccines at two large sexually transmitted infection clinics in British Columbia, Canada.加拿大不列颠哥伦比亚省两家大型性传播感染诊所中与细菌性传播感染疫苗接种意愿相关的因素。
Sex Transm Infect. 2020 Nov;96(7):494-500. doi: 10.1136/sextrans-2019-054311. Epub 2020 May 26.
6
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.HPV 疫苗犹豫对日本宫颈癌的影响:建模研究。
Lancet Public Health. 2020 Apr;5(4):e223-e234. doi: 10.1016/S2468-2667(20)30010-4. Epub 2020 Feb 10.
7
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.CTH522 佐剂用 CAF01 脂质体或氢氧化铝的衣原体疫苗候选物的安全性和免疫原性:首次人体、随机、双盲、安慰剂对照、1 期试验。
Lancet Infect Dis. 2019 Oct;19(10):1091-1100. doi: 10.1016/S1473-3099(19)30279-8. Epub 2019 Aug 12.
8
Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: There is no time like the present.应对淋病及耐药性淋病发病率的上升:刻不容缓。
Can Commun Dis Rep. 2019 Feb 7;45(2-3):54-62. doi: 10.14745/ccdr.v45i23a02.
9
Risk Factors Associated with Self-reported Sexually Transmitted Infections among Postsecondary Students in Canada.加拿大高等院校学生自我报告的性传播感染相关风险因素
Int J Prev Med. 2018 Jun 4;9:49. doi: 10.4103/ijpvm.IJPVM_444_17. eCollection 2018.
10
Vaccine acceptance, hesitancy and refusal in Canada: Challenges and potential approaches.加拿大的疫苗接受度、犹豫态度和拒绝情况:挑战与潜在应对方法。
Can Commun Dis Rep. 2016 Dec 1;42(12):246-251. doi: 10.14745/ccdr.v42i12a02.